Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,613 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease.
Xu J, Bankov G, Kim M, Wretlind A, Lord J, Green R, Hodges A, Hye A, Aarsland D, Velayudhan L, Dobson RJB, Proitsi P, Legido-Quigley C; AddNeuroMed Consortium. Xu J, et al. Among authors: lord j. Transl Neurodegener. 2020 Sep 21;9(1):36. doi: 10.1186/s40035-020-00215-0. Transl Neurodegener. 2020. PMID: 32951606 Free PMC article.
Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.
Zettergren A, Lord J, Ashton NJ, Benedet AL, Karikari TK, Lantero Rodriguez J; Alzheimer’s Disease Neuroimaging Initiative*; Snellman A, Suárez-Calvet M, Proitsi P, Zetterberg H, Blennow K. Zettergren A, et al. Among authors: lord j. Alzheimers Res Ther. 2021 Jan 8;13(1):17. doi: 10.1186/s13195-020-00754-8. Alzheimers Res Ther. 2021. PMID: 33419453 Free PMC article.
A genome-wide association study of plasma phosphorylated tau181.
Lord J, Zettergren A, Ashton NJ, Karikari TK, Benedet AL, Simrén J; Alzheimer's Disease Neuroimaging Initiative; Hye A, Aarsland D; AddNeuroMed consortium; Blennow K, Zetterberg H, Proitsi P. Lord J, et al. Neurobiol Aging. 2021 Oct;106:304.e1-304.e3. doi: 10.1016/j.neurobiolaging.2021.04.018. Epub 2021 May 4. Neurobiol Aging. 2021. PMID: 34119372 Free article.
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort.
Xu J, Green R, Kim M, Lord J, Ebshiana A, Westwood S, Baird AL, Nevado-Holgado AJ, Shi L, Hye A, Snowden SG, Bos I, Vos SJB, Vandenberghe R, Teunissen CE, Kate MT, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck EE, Engelborghs S, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey FRJ, Alcolea D, Lleó A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Proitsi P, Legido-Quigley C, On Behalf Of The European Medical Information Framework Consortium. Xu J, et al. Among authors: lord j. Biomedicines. 2021 Nov 3;9(11):1610. doi: 10.3390/biomedicines9111610. Biomedicines. 2021. PMID: 34829839 Free PMC article.
Disentangling Independent and Mediated Causal Relationships Between Blood Metabolites, Cognitive Factors, and Alzheimer's Disease.
Lord J, Green R, Choi SW, Hübel C, Aarsland D, Velayudhan L, Sham P, Legido-Quigley C, Richards M, Dobson R, Proitsi P; Alzheimer’s Disease Neuroimaging Initiative; GERAD1 Consortium, and AddNeuroMed. Lord J, et al. Biol Psychiatry Glob Open Sci. 2021 Aug 4;2(2):167-179. doi: 10.1016/j.bpsgos.2021.07.010. eCollection 2022 Apr. Biol Psychiatry Glob Open Sci. 2021. PMID: 36325159 Free PMC article.
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adults.
Leffa DT, Ferrari-Souza JP, Bellaver B, Tissot C, Ferreira PCL, Brum WS, Caye A, Lord J, Proitsi P, Martins-Silva T, Tovo-Rodrigues L, Tudorascu DL, Villemagne VL, Cohen AD, Lopez OL, Klunk WE, Karikari TK, Rosa-Neto P, Zimmer ER, Molina BSG, Rohde LA, Pascoal TA; Alzheimer’s Disease Neuroimaging Initiative. Leffa DT, et al. Among authors: lord j. Mol Psychiatry. 2023 Mar;28(3):1248-1255. doi: 10.1038/s41380-022-01867-2. Epub 2022 Dec 8. Mol Psychiatry. 2023. PMID: 36476732
Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease.
Green RE, Lord J, Scelsi MA, Xu J, Wong A, Naomi-James S, Handy A, Gilchrist L, Williams DM, Parker TD, Lane CA, Malone IB, Cash DM, Sudre CH, Coath W, Thomas DL, Keuss S, Dobson R, Legido-Quigley C, Fox NC, Schott JM, Richards M, Proitsi P; Insight 46 study team. Green RE, et al. Among authors: lord j. Alzheimers Res Ther. 2023 Feb 22;15(1):38. doi: 10.1186/s13195-023-01184-y. Alzheimers Res Ther. 2023. PMID: 36814324 Free PMC article.
1,613 results